BP000403-TBE-289: Recombinant TBEV NE/GE/CE
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000403-TBE-285: Recombinant TBEV Core Protein
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP000403-TBE-287: Recombinant TBEV preM
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WB, ELISA.BP002223-PRO-860: Recombinant Human Tissue Factor Pathway Inhibitor 2 (TFPI2) protein
Source: Nicotiana benthamiana-derived.
Purity: > 97.0% as determined by SDS-PAGE.BP002225-PRO-095: Recombinant Human Transcription factor A (TFAM) Protein
Source: E. coli-derived.
Purity: > 85.0% as determined by SDS-PAGE.BP002210-PRO-776: Recombinant Human Translationally-controlled tumor (TCTP) Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP001768-CYT-043: Recombinant Human Tumor Necrosis Factor Receptor Superfamily Member 12A (TNFRSF12A) Protein
Source: E. coli-derived.
The TNFRSF12A biological activity is determined by its ability to inhibit TWEAK-induced weak cell death of HT29 cells. The expected ED50 for this effect is 1.0-5.0 ug/ml in the presence of 1 ug/ml rhTWEAK.
Purity: > 97.0% by HPLC and SDS-PAGE.BP002458-CYT-069: Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) Protein
Source: E. coli-derived.
The TNFRSF10B reduced the production of LPS-induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/mL) but in the presence of TNFRSF10B, TRAIL-induced TNF is suppressed.
Purity: > 95.0% by SDS-PAGE.BP000123-CYT-114: Recombinant Human Tumor Necrosis Factor-Alpha (TNFα) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent cytotoxity of the TNF alpha sensitive cell line L-929 in the presence of Actinomycin D and is typically 0.05-0.5 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000123-CYT-384: Recombinant Human Tumor Necrosis Factor α Mutant
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is < 0.05 ng/ml, corresponding to a Specific Activity of 20,000,000 units/mg.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.